
### [MONDO:0016569](http://purl.obolibrary.org/obo/MONDO_0016569)
**Label:** rare lymphatic malformation

**Subclasses:** [MONDO:0019328](http://purl.obolibrary.org/obo/MONDO_0019328) (macrocystic lymphatic malformation), [MONDO:0019329](http://purl.obolibrary.org/obo/MONDO_0019329) (microcystic lymphatic malformation), [MONDO:0018735](http://purl.obolibrary.org/obo/MONDO_0018735) (multifocal lymphangioendotheliomatosis-thrombocytopenia syndrome), [MONDO:0007414](http://purl.obolibrary.org/obo/MONDO_0007414) (Gorham-Stout disease), [MONDO:0018720](http://purl.obolibrary.org/obo/MONDO_0018720) (common cystic lymphatic malformation), [MONDO:0009761](http://purl.obolibrary.org/obo/MONDO_0009761) (cystic hygroma), [MONDO:0015408](http://purl.obolibrary.org/obo/MONDO_0015408) (diffuse lymphatic malformation), [MONDO:0013324](http://purl.obolibrary.org/obo/MONDO_0013324) (lymphedema-posterior choanal atresia syndrome), [MONDO:0018717](http://purl.obolibrary.org/obo/MONDO_0018717) (mixed cystic lymphatic malformation), 

**Mapped go classes:** [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0006470](http://purl.obolibrary.org/obo/GO_0006470) (protein dephosphorylation), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0046825](http://purl.obolibrary.org/obo/GO_0046825) (regulation of protein export from nucleus), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0004721](http://purl.obolibrary.org/obo/GO_0004721) (phosphoprotein phosphatase activity), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0003712](http://purl.obolibrary.org/obo/GO_0003712) (transcription cofactor activity), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0004725](http://purl.obolibrary.org/obo/GO_0004725) (protein tyrosine phosphatase activity), [GO:0016791](http://purl.obolibrary.org/obo/GO_0016791) (phosphatase activity), [GO:0001946](http://purl.obolibrary.org/obo/GO_0001946) (lymphangiogenesis), [GO:0016311](http://purl.obolibrary.org/obo/GO_0016311) (dephosphorylation), [GO:0030971](http://purl.obolibrary.org/obo/GO_0030971) (receptor tyrosine kinase binding), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm) 75.00%
- [GO:0001946](http://purl.obolibrary.org/obo/GO_0001946) (lymphangiogenesis) 75.00%
- Thing 50.90%
- [GO:0048646](http://purl.obolibrary.org/obo/GO_0048646) (anatomical structure formation involved in morphogenesis) 30.24%
- [GO:0044428](http://purl.obolibrary.org/obo/GO_0044428) (nuclear part) 29.15%
- [GO:0009653](http://purl.obolibrary.org/obo/GO_0009653) (anatomical structure morphogenesis) 28.67%
- [GO:0044446](http://purl.obolibrary.org/obo/GO_0044446) (intracellular organelle part) 27.80%
- [GO:0044422](http://purl.obolibrary.org/obo/GO_0044422) (organelle part) 27.67%
- [GO:0044424](http://purl.obolibrary.org/obo/GO_0044424) (intracellular part) 27.29%
- [GO:0044464](http://purl.obolibrary.org/obo/GO_0044464) (cell part) 26.99%
- [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) 26.86%
- [GO:0032502](http://purl.obolibrary.org/obo/GO_0032502) (developmental process) 26.79%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 25.82%
- [GO:0000047](http://purl.obolibrary.org/obo/GO_0000047) (obsolete Rieske iron-sulfur protein) 0.00%
- [GO:0000046](http://purl.obolibrary.org/obo/GO_0000046) (null) 0.00%


